Thilo Schroeder, Director at PMV Pharmaceuticals, Inc. (PMVP), sold 192,172 shares at $34.74 ($6.7M) on 2021-08-02, disclosed to the SEC on 2021-08-04.
Open-market sale of $6.7M PMVP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.74 | 13,031 | $453K | 6.7% |
| 2 | $34.74 | 13,031 | $453K | 6.7% |
| 3 | $33.80 | 30,145 | $1.0M | 15.1% |
| 4 | $33.80 | 30,145 | $1.0M | 15.1% |
| 5 | $34.74 | 100 | $3K | 0.1% |
| 6 | $34.21 | 1,760 |
| $60K |
| 0.9% |
| 7 | $34.21 | 1,760 | $60K | 0.9% |
| 8 | $35.10 | 17,175 | $603K | 8.9% |
| 9 | $35.10 | 17,175 | $603K | 8.9% |
| 10 | $36.22 | 28,676 | $1.0M | 15.4% |
| 11 | $36.22 | 28,676 | $1.0M | 15.4% |
| 12 | $36.80 | 5,249 | $193K | 2.9% |
| 13 | $36.80 | 5,249 | $193K | 2.9% |
| Total | $35.05 avg | 192,172 | $6.7M | 100% |
| Filing → |
| RVMD | BUY | 2022-07-26 | $5.0M | — | Filing → |
| RVMD | BUY | 2022-03-29 | $2.1M | — | Filing → |
| RVMD | BUY | 2022-03-24 | $11.0M | — | Filing → |